COVID-19 hospitalized patients frequently have underlying AF, which confers a higher risk of adverse hospital outcomes and mortality, even after adjusting for baseline comorbidities. Heightened awareness is needed in the treatment of hospitalized COVID-19 patients with AF.
Keyphrases
- coronavirus disease
- atrial fibrillation
- sars cov
- end stage renal disease
- risk factors
- ejection fraction
- chronic kidney disease
- newly diagnosed
- respiratory syndrome coronavirus
- heart failure
- healthcare
- left atrial
- peritoneal dialysis
- oral anticoagulants
- cardiovascular events
- catheter ablation
- direct oral anticoagulants
- cardiovascular disease
- adipose tissue
- coronary artery disease
- insulin resistance
- acute coronary syndrome
- weight loss
- mitral valve
- electronic health record
- smoking cessation
- left ventricular